Jonathan I Lieber Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Jonathan I Lieber.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Jonathan I Lieber. Jonathan I Lieber is a VP, CFO and Treasurer in Altus Pharmaceuticals Inc. ($ALTU) and a Chief Financial Officer in HISTOGENICS CORP ($HSGX) and a Director in Salarius Pharmaceuticals, Inc. ($FLKS).
Address: C/O ALTUS PHARMACEUTICALS INC. 125 SIDNEY STREET CAMBRIDGE 02139 MA
Companies in which Jonathan I Lieber is an Insider
Altus Pharmaceuticals Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Jonathan I Lieber: VP, CFO and Treasurer
Holdings: 0 shares
Latest Transaction: Dec 18 2007
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Ocugen, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Jonathan I Lieber: Chief Financial Officer
Holdings: 5,000 shares
Current Value: $8,300
Latest Transaction: Oct 03 2018
$HSGX Market Capitalization: $28.25M
$HSGX Previous Close: $1.66
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Salarius Pharmaceuticals, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Jonathan I Lieber: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Dec 04 2020
$FLKS Market Capitalization: $76.20M
$FLKS Previous Close: $4.67
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Jonathan I Lieber
Sentiment: All, ALTU, HSGX, FLKS
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 04 2020 | FLKS | Salarius Pharmaceu ... | Lieber Jonathan I | Director | Option Exercise | A | 0.74 | 30,000 | 22,200 | 30,000 | |
| Jul 16 2020 | FLKS | Salarius Pharmaceu ... | Lieber Jonathan I | Director | Option Exercise | A | 1.32 | 3,000 | 3,960 | 3,000 | |
| Oct 03 2018 | HSGX | HISTOGENICS CORP | Lieber Jonathan I | Chief Financial Off ... | Option Exercise | D | 6.37 | 30,000 | 191,100 | 0 | |
| Oct 03 2018 | HSGX | HISTOGENICS CORP | Lieber Jonathan I | Chief Financial Off ... | Option Exercise | A | 0.57 | 130,000 | 73,840 | 130,000 | |
| Oct 03 2018 | HSGX | HISTOGENICS CORP | Lieber Jonathan I | Chief Financial Off ... | Option Exercise | D | 2.63 | 130,000 | 341,900 | 0 | |
| Oct 03 2018 | HSGX | HISTOGENICS CORP | Lieber Jonathan I | Chief Financial Off ... | Option Exercise | A | 0.57 | 50,000 | 28,400 | 50,000 | |
| Oct 03 2018 | HSGX | HISTOGENICS CORP | Lieber Jonathan I | Chief Financial Off ... | Option Exercise | D | 1.72 | 50,000 | 86,000 | 0 |